Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Quipt Home Medical (QIPT – Research Report) today and set a price target of ...
In a report released today, Paul Matteis from Stifel Nicolaus reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback